Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance i...
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
About this item
Full title
Author / Creator
Publisher
Germany: Beilstein-Institut zur Föerderung der Chemischen Wissenschaften
Journal title
Language
English
Formats
Publication information
Publisher
Germany: Beilstein-Institut zur Föerderung der Chemischen Wissenschaften
Subjects
More information
Scope and Contents
Contents
Resistance to systemic drug therapy is a major reason for the failure of anticancer therapies. Here, we tested doxorubicin-loaded human serum albumin (HSA) nanoparticles in the neuroblastoma cell line UKF-NB-3 and its ABCB1-expressing sublines adapted to vincristine (UKF-NB-3
VCR
) and doxorubicin (UKF-NB-3
DOX
). Doxorubicin-loaded nan...
Alternative Titles
Full title
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5689f5d2bf47444c8e464bfaf5e9ac5a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5689f5d2bf47444c8e464bfaf5e9ac5a
Other Identifiers
ISSN
2190-4286
E-ISSN
2190-4286
DOI
10.3762/bjnano.10.166
